Agios Pharmaceuticals, Inc. (LON:0HB0)
London · Delayed Price · Currency is GBP · Price in USD 27.30
-0.20 (-0.73%)
At close: Dec 5, 2025
Agios Pharmaceuticals Market Cap
Agios Pharmaceuticals has a market cap or net worth of 1.21 billion as of December 5, 2025. Its market cap has decreased by -50.43% in one year.
Market Cap
1.21B
Enterprise Value
303.49M
Revenue
33.32M
Ranking
n/a
PE Ratio
n/a
Stock Price
27.30
Market Cap Chart
Since July 24, 2013, Agios Pharmaceuticals's market cap has increased from 613.73M to 1.21B, an increase of 97.75%. That is a compound annual growth rate of 5.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 1.21B | -18.92% |
| Dec 31, 2024 | 1.50B | 53.18% |
| Dec 29, 2023 | 977.19M | -23.69% |
| Dec 30, 2022 | 1.28B | -2.87% |
| Dec 31, 2021 | 1.32B | -40.02% |
| Dec 31, 2020 | 2.20B | -10.83% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 212.35B |
| GSK plc | 73.29B |
| Haleon | 32.16B |
| Smith & Nephew | 10.44B |
| Convatec Group | 4.46B |
| Hikma Pharmaceuticals | 3.52B |
| HUTCHMED (China) | 1.84B |
| Genus | 1.77B |